HOME >> BIOLOGY >> NEWS
Henney To Address Attendees At FDA Science Forum

Alexandria, VA -- The new FDA Commissioner, Dr. Jane Henney, will arrive at FDA in time to participate in the 1998 FDA Science Forum, co-sponsored by the American Association of Pharmaceutical Scientists (AAPS). Dr. Henney will discuss the importance of science in biotechnology regulation with FDA scientists and the external scientific community.

AAPS is co-sponsoring the 1998 FDA Science Forum, titled "Biotechnology: Advances, Applications, and Regulatory Challenges," with FDA and the FDA Chapter of Sigma Xi at the Washington Convention Center in Washington, D.C., Dec. 8-9, 1998.

The FDA Science Forum is open to the public and will bring FDA research and review scientists together with representatives of industry, academia, government agencies, consumer groups, and the public to discuss the impact of the enormous advances in biotechnology on product development and regulation. The program will encompass bioengineered products, novel therapeutic and preventive approaches, diagnostics and detection methodologies, and safety and efficacy assessment. Regulatory issues related to standards, product quality and the impact of the Food and Drug Administration Modernization Act (FDAMA) will also be addressed. For more information, contact: AAPS, 703-548-3000, email: meetings@aaps.org, www.aaps.org/edumeet.html (registration materials available online).

The American Association of Pharmaceutical Scientists is a professional, scientific society of more than 9,300 members employed in academia, industry, government, and other research institutions worldwide. Founded in 1986, the goal of AAPS is to improve human health through the development of better pharmaceuticals.


'"/>

Contact: Amy J. Miller
miller@aaps.org
703-518-8417
American Association of Pharmaceutical Scientists
2-Oct-1998


Page: 1

Related biology news :

1. Addressing the Healthcare Needs of Our Aging Population with Technology
2. Top Experts To Address Top Food Safety Concerns At IFT Meeting
3. Nutritional Needs Of The Future To Be Addressed At IFT Meeting
4. Maggots Could Help Address Problems Of Antibiotic Resistance
5. Scientists Devise Method To Address Conflict Between Molecular Clock, Fossil Record Of Mammalian Evolution
6. Vasta To Address Diseases Of Marine Environment At AAAS Meeting
7. International Conference Addresses Drug-Resistant TB Epidemic Ravaging Russia
8. IFT/NCFST Symposium To Address Safety Of Fresh Produce
9. Reclaimed Waste Water Can Augment Municipal Drinking-Water Supplies But Concerns Must Be Addressed
10. A long-necked sea predator from China described in Science
11. Brown ecologist garners major National Science Foundation grant

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Henney Address Attendees FDA Science Forum

(Date:1/22/2015)... Jan. 21, 2015  Analyst Report Issued by Small Cap IR. ... showed that planet-wide, transactions at merchants on the leading payment ... number of credit, debit, and prepaid cards reached 6.54 billion.  ... of fraudulent card usage in 2012, and credit and debit ...
(Date:1/22/2015)... Research and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ) ... Wearable Technologies Market and Applications, Opportunities, Industry Analysis, ... 2014-2020" report to their offering. , ... can be worn on the user,s body and ...
(Date:1/22/2015)... has launched its new NXG series of time clocks with ... higher standard for collecting attendance and labor data and complements ... touch screen interface and seamless connection to cloud-based iSolved, the ... for the small to mid-size employer. The G2 ...
Breaking Biology News(10 mins):$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2Infinisource's NXG series sets new time clock standard 2
(Date:2/27/2015)... Calif. , Feb. 27, 2015  Steep Hill, ... the US and internationally, intends to open a full ... Albuquerque, New Mexico , bringing advanced scientific tools ... cannabis. Steep Hill is currently the only ... to conduct potency and contaminant testing in order to ...
(Date:2/26/2015)... YORK , Feb. 26, 2015 S&P ... Factual Stock Report coverage on MabVax Therapeutics Holdings ... (MBVX) is a clinical stage biotechnology company focused on ... unmet medical needs in the treatment of cancer. MabVax ... based on the protective immune responses generated by patients ...
(Date:2/26/2015)... , Feb. 26, 2015  23andMe, the leading ... Kate Black as Privacy Officer and Corporate Counsel. ... state privacy laws as well as health care regulations. ... she will be responsible for reviewing, updating and enhancing ... the U.S. and abroad. She joined the company January ...
(Date:2/26/2015)... Feb. 26, 2015   Synageva BioPharma Corp. ... company developing therapeutic products for rare disorders, today ... 2015 goals, other key objectives, and financial guidance.  ... today at 4:30 p.m. EST to review the ... To participate in today,s call by telephone, please ...
Breaking Biology Technology:Steep Hill First to Receive Provisional Approval to Establish Laboratory Services for Cannabis Testing in State of New Mexico 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 523andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9
Cached News: